HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology

BACKGROUND: The therapeutic HIV-1 Tat protein vaccine is in advanced clinical development. Tuberculosis, the main AIDS co-infection, is highly endemic in areas where AIDS prevention through vaccination is needed. However, safety and immunogenicity of Tat vaccination in the course of Mycobacterium tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cafaro, Aurelio, Piccaro, Giovanni, Altavilla, Giuseppe, Gigantino, Vincenzo, Matarese, Giuseppe, Olivieri, Erika, Ferrantelli, Flavia, Ensoli, Barbara, Palma, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994248/
https://www.ncbi.nlm.nih.gov/pubmed/27549342
http://dx.doi.org/10.1186/s12879-016-1724-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994248/
https://www.ncbi.nlm.nih.gov/pubmed/27549342
http://dx.doi.org/10.1186/s12879-016-1724-7

Ejemplares similares